Probiodrug to Present Potential New Treatment for Alzheimer’s Disease

Probiodrug announces appointment of Prof Dr Harald Labischinski and Dr Jonathan David Turner to its Board of Directors
Nature Medicine Publikation erläutert Probiodrugs neues Paradigma zur Behandlung der Alzheimer-Erkrankung